Kansal Mohit, an officer at Flywire Corp, has filed a notice to sell 6,053 shares of the company. This sale is valued at approximately $126,507.70 and is part of a series of stock transactions involving Mohit. The filing is significant as it highlights ongoing executive activity within Flywire, a player in the business services sector.
Background
Flywire Corp, identified under the Central Index Key 0001580560, operates in the business services sector, specifically categorized under Services-Business Services, NEC. The company is incorporated in Delaware and has its headquarters at 141 Tremont Street, Suite 10, Boston, MA. It trades on the NASDAQ under the SEC file number 001-40430. Recent filings show a consistent pattern of stock transactions by its officers.
What the Filing Says
The filing, dated November 4, 2026, indicates that Kansal Mohit is selling shares acquired through restricted stock vesting and stock option exercises. Specifically, the shares were acquired on March 4, 2025, and March 12, 2025. The notice states, "Kansal Mohit is selling 6,053 shares of common stock, with an aggregate market value of $126,507.70."
Impact
This sale may impact Flywire's stock dynamics, particularly as it reflects the liquidity and trading patterns of its executives. Such transactions can influence investor perceptions and market activity, especially within the business services sector. The filing also shows that Mohit previously sold 12,464 shares on September 2, 2026, for gross proceeds of $222,918.64, indicating a trend of active trading.
What's Next
The filing does not say what happens next regarding the sale or any future transactions by Mohit. Investors and analysts will likely monitor any additional filings or disclosures from Flywire Corp for further insights into executive trading activities.
Read Next
TXSE Group Inc. raises $10 million in private offering
CCI 1026 a Series of CGF2026 LLC Completes Fundraising Update
JAMESTOWN Premier Property Fund amends private offering details
Lloyds Banking Group Announces Share Buyback of 10 Million
Morgan Stanley Finance files for new structured investment product
Bristol Myers Squibb director Julia Haller to sell shares







